• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    More On TTH.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Transition Therapeutics Inc. (TTH.TO)

    -Toronto
    0.97 Down 0.08(7.62%) Apr 29
    Prev Close:1.05
    Open:1.00
    Bid:0.98
    Ask:0.99
    1y Target Est:N/A
    Beta:2.79113
    Earnings Date:May 10 - May 16 (Est.)
    Day's Range:0.94 - 1.06
    52wk Range:0.94 - 11.50
    Volume:41,777
    Avg Vol (3m):19,270
    Market Cap:37.71M
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:0.06 (0.20%)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for TTH.TO

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :N/A
    Quarterly EPS Est (Jun-15) :N/A
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback